IP Library Granted Patent US 11,577,060
Granted Patent B2
US 11,577,060 · App. 16/742,870 · Granted Feb 14, 2023

Systems and methods for the conditioning of cerebrospinal fluid

Inventors: Blake Hedstrom (Minneapolis, MN); Shivanand P. Lad (Durham, NC); Aaron Mccabe (Edina, MN); Emily Meyering (St. Louis Park, MN); Jack Mondry (Edina, MN); Amrita Sawhney (Princeton Junction, NJ); Elizabeth Scheurer (Minneapolis, MN); Matthew Stoll (Minneapolis, MN); Abhi Vase (Los Altos Hills, CA)
Assignee: MINNETRONIX, INC.
A61M27/006A61M2025/0031A61M2205/053A61M2205/054A61M2205/3344A61M2205/36A61M2205/50A61M2205/75A61M2230/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,577,060
App. No.
16/742,870
Granted
Feb 14, 2023
Kind
B2
Abstract

Systems and methods for treating biologic fluids are disclosed. Some disclosed embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject, heat CSF to a target temperature, cool CSF to a target temperature, apply light treatment to CSF, separate cells via their dielectric properties, apply spiral and/or centrifugal separation, introduce additives to target particles, and/or apply combinations thereof. The method may include the steps of withdrawing fluid comprising CSF, treating the fluid, and returning a portion of the treated fluid to the subject. During operation of the system, various parameters may be modified, such as flow rate.

Claims (35)

1. A system for treating cerebrospinal fluid of a human or animal subject, the system comprising:

a catheter assembly including a first fluid pathway and a second fluid pathway;

a tangential flow filter coupled to the catheter assembly, the tangential flow filter being in fluid communication with the first fluid pathway and being in fluid communication with the second fluid pathway;

a pump configured to withdraw a volume of cerebrospinal fluid from the human or animal subject and transfer the volume of cerebrospinal fluid to the tangential flow filter along the first fluid pathway;

wherein the tangential flow filter is configured to filter the volume of cerebrospinal fluid into a permeate and a retentate;

wherein the pump is configured to return at least a portion of the permeate to the human or animal subject along the second fluid pathway; and

a processing unit configured to increase a rate at which the volume of cerebrospinal fluid passes through the tangential flow filter by diverting a diverted portion of the permeate or retentate back through the tangential flow filter.

2. The system of claim 1 , further comprising a sensor disposed adjacent to the tangential flow filter.

3. The system of claim 2 , wherein the sensor is configured to measure a characteristic of the volume of cerebrospinal fluid.

4. The system of claim 3 , wherein the characteristic is a difference between a first flow rate along the first fluid pathway and a second flow rate along the second fluid pathway.

5. The system of claim 3 , wherein the characteristic is a difference between a first fluid volume along the first fluid pathway and a second fluid volume along the second fluid pathway.

6. The system of claim 3 , wherein the processing unit is configured to update a parameter of a set of operation parameters based on the measured characteristic responsive to determining that the measured characteristic passes a predetermined threshold.

7. The system of claim 1 , wherein the pump is configured to withdraw the volume of cerebrospinal fluid from the human or animal subject at a first flow rate and the pump is configured to return at least the portion of the permeate to the human or animal subject at a second flow rate different from the first flow rate.

8. The system of claim 1 , further comprising an inactivating member coupled to the tangential flow filter.

9. The system of claim 8 , wherein the inactivating member includes a heating member.

10. The system of claim 8 , wherein the inactivating member includes a cooling member.

11. The system of claim 8 , wherein the inactivating member includes an ultraviolet radiation member.

12. A system for treating cerebrospinal fluid of a human or animal subject, the system comprising:

a catheter assembly including a first fluid pathway and a second fluid pathway;

a tangential flow filter coupled to the catheter assembly, the tangential flow filter being in fluid communication with the first fluid pathway and being in fluid communication with the second fluid pathway; and

an inactivating member coupled to the tangential flow filter, the inactivating member being configured to inactivate a target microorganism.

13. The system of claim 12 , wherein the inactivating member includes a heating member.

14. The system of claim 12 , wherein the inactivating member includes a cooling member.

15. The system of claim 12 , wherein the inactivating member includes an ultraviolet radiation member.

16. A system for treating cerebrospinal fluid, the system comprising:

a catheter assembly including a first fluid pathway and a second fluid pathway;

a separation member coupled to the catheter assembly, the separation member being in fluid communication with the first fluid pathway and being in fluid communication with the second fluid pathway;

a pump configured to withdraw a volume of cerebrospinal fluid from a patient and transfer the volume of cerebrospinal fluid to the separation member via the first fluid pathway;

wherein the separation member is configured to separate the volume of cerebrospinal fluid into a treated volume and a waste volume;

wherein the pump is configured to return at least a portion of the treated volume to the patient via the second fluid pathway; and

a processing unit configured to increase a rate at which the volume of cerebrospinal fluid passes through the separation member by diverting a diverted portion of the treated volume, a diverted portion of the waste volume, or both back to the separation member.

17. The system of claim 16 , wherein the separation member includes a tangential flow filter.

18. The system of claim 16 , further comprising a sensor disposed adjacent to the separation member, the sensor being configured to measure a characteristic of the volume of cerebrospinal fluid.

19. The system of claim 18 , wherein the processing unit is configured to update a parameter of a set of operation parameters based on the measured characteristic responsive to determining that the measured characteristic passes a predetermined threshold.

20. The system of claim 16 , further comprising an inactivating member coupled to the separation member.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2025
From: MINNETRONIX NEURO, INC.
To: PHARAOH NEURO, INC.
Reel/Frame 073429/0607 →
RELEASE OF PATENT SECURITY AGREEMENT - REEL/FRAME 054795/0607, SUPPLEMENTAL PATENT SECURITY AGREEMENT - REAL/FRAME 056240/0147 AND ASSIGNMENT ID: 885388 Recorded Oct 1, 2025
From: TEXAS CAPITAL BANK, AS AGENT
To: MINNETRONIX MEDICAL, INC.
Reel/Frame 073434/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: MINNETRONIX, INC.
To: MINNETRONIX NEURO, INC.
Reel/Frame 071588/0980 →
PARTIAL RELEASE OF PATENT SECURITY AGREEMENT - REEL 054795 FRAME 0607; AND REEL 056240 FRAME 0147 Recorded Jun 10, 2025
From: TEXAS CAPITAL BANK, AS ADMINISTRATIVE AGENT
To: MINNETRONIX, INC.; MINNETRONIX NEURO, INC. (F/K/A NEUROFLUIDICS, INC.)
Reel/Frame 071588/0015 →
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON REEL 054795 FRAME 0607 AND SUPPLEMENTAL PATENT SECURITY AGREEMENT RECORDED ON REEL 056240 FRAME 0147 Recorded Mar 13, 2025
From: FIRST HORIZON BANK
To: TEXAS CAPITAL BANK, AS SUCCESSOR AGENT
Reel/Frame 073460/0969 →
SECURITY INTEREST Recorded Jan 4, 2021
From: MINNETRONIX MEDICAL, INC.; MINNETRONIX NEURO, INC.
To: FIRST HORIZON BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 054795/0607 →